Vericel Corp (VCEL) stock
VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$57.88+0.40 (+0.70%)
Close on Nov 17, 2026Market cap $2.96BP/E 137.8Yield –
Vericel total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Vericel's total debt was $13.18M at Sep 30, 2018. For fiscal 2017 it was $16.89M, up 81.2% from the year before. The highest annual figure on record is $16.89M in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $16.89M | +81.2% |
| FY2016 | Dec 31, 2016 | $9.32M | +13023.9% |
| FY2015 | Dec 31, 2015 | $71.00K | -34.9% |
| FY2014 | Dec 31, 2014 | $109.00K | +808.3% |
| FY2013 | Dec 31, 2013 | $12.00K | -70.0% |
| FY2012 | Dec 31, 2012 | $40.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2018 | Sep 30, 2018 | $13.18M | +78.1% |
| Q2 FY2018 | Jun 30, 2018 | $14.42M | +79.3% |
| Q1 FY2018 | Mar 31, 2018 | $15.65M | +80.3% |
| Q4 FY2017 | Dec 31, 2017 | $16.89M | +81.2% |
| Q3 FY2017 | Sep 30, 2017 | $7.40M | +17519.0% |
| Q2 FY2017 | Jun 30, 2017 | $8.04M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.68M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.32M | – |
| Q3 FY2016 | Sep 30, 2016 | $42.00K | – |
See a number that looks wrong?